1-20 of 44
Francesco Lanza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Centralized MRD Assessment in Gimema AML1718 Trial, a Phase 2 Open-Label Study of Venetoclax Combined with Intensified FLAI Chemotherapy (V-FLAI) As Induction Therapy of Non Low-Risk AML

Paola Minetto, Fabio Guolo, Sara Rosellini, Alfonso Piciocchi, Giovanni Marconi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Giovanni Marsili, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo Giovanni Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Valentina Arena, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Elisabetta Tedone, Giovanni Martinelli, Roberto Massimo Lemoli
Journal: Blood
Blood (2024) 144 (Supplement 1): 1574.
https://doi.org/10.1182/blood-2024-198139
Published: 2024
Journal Articles

Reaction - Real Life Use of Ravulizumab in Italian Patients with Paroxysmal Nocturnal Hemoglobinuria a Multicenter Observational Retrospective and Prospective Cohort Study, Final Results

Bruno Fattizzo, Anna Paola Iori, Antonio De Vivo, Elisabetta Metafuni, Amalia Figuera, Luana Marano, Esther Natalie Oliva, Maria Bruna Greve, Francesco Lanza, Eros Di Bona, Jacopo Micozzi, Giovanni Caocci, Francesca Fioritoni, Fabio Ciceri, Angela Amendola, Carmine Selleri, Francesco Longu, Alessandra Tucci, Eloise Beggiato, Davide Rapezzi, Alessandro Cignetti, Tiziana Anna Urbano, Nicola Di Renzo, Valeria Amico, Pierangelo Spedini, Alessandro Rambaldi, Simona Raso, Cristina Clissa, Sergio Cabibbo, Barbara Roncari, Lucia Simoni, Benedetta Campolo, Fabio Carini, Davide Mattiuzzi, Wilma Barcellini
Journal: Blood
Blood (2024) 144 (Supplement 1): 2464.
https://doi.org/10.1182/blood-2024-204659
Published: 2024
Journal Articles

Efficacy and Safety of Uproleselan Combined with Chemotherapy Vs. Chemotherapy Alone in Relapsed/Refractory Acute Myeloid Leukemia: Findings from an International Phase 3 Trial

Daniel J. DeAngelo, Andre C. Schuh, Brian A. Jonas, Pamela S. Becker, Anjali S. Advani, Geoffrey L. Uy, Janusz Krawczyk, Harry P. Erba, Gabriel N Mannis, Chun Yew Fong, Florian Kuchenbauer, Mary-Elizabeth M. Percival, Jane L. Liesveld, William Blum, Brenda W Cooper, Alice Mims, Francesco Lanza, Jeroen J.W.M. Janssen, Juan Miguel Bergua Burgues, Tibor Kovacsovics, Norbert Vey, Martina V. Hemmer, Gaetano Bonifacio, Edwin Rock, Pau Montesinos
Journal: Blood
Blood (2024) 144 (Supplement 1): 733.
https://doi.org/10.1182/blood-2024-209097
Published: 2024
Journal Articles

Late Hematologic Recovery after CPX-351 Induction Chemotherapy in AML: Predictive Disease and Patient's Factors and Their Impact on Survival

Michela Rondoni, Paola Minetto, Bruna Puglisi, Francesco Saraceni, Lorenzo Brunetti, Anna Maria Mianulli, Monica Bocchia, Adele Santoni, Carola Riva, Barbara Giannini, Federica Monaco, Beatrice Zannetti, Claudia Cellini, Annalisa Nicoletti, Anna Maria Valenti, Debora Capelli, Donatella Raspadori, Attilio Olivieri, Francesco Lanza, Claudio Graziano, Patrizia Tosi, Roberto Massimo Lemoli, Fabio Guolo
Journal: Blood
Blood (2023) 142 (Supplement 1): 4275.
https://doi.org/10.1182/blood-2023-182993
Published: 2023
Journal Articles

Centralized MRD Assessment at Early Timepoints in Gimema AML1718 Trial, a Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk AML

Paola Minetto, Fabio Guolo, Sara Rosellini, Alfonso Piciocchi, Giovanni Marconi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paola Paoloni, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo Giovanni Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Valentina Arena, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Elisabetta Tedone, Giovanni Martinelli, Roberto M. Lemoli
Journal: Blood
Blood (2023) 142 (Supplement 1): 1567.
https://doi.org/10.1182/blood-2023-189777
Published: 2023
Journal Articles

CNS Prophylaxis in Adult ALL Patients after Stem Cell Transplantation: An EBMT Survey on General Practice

Patrizia Chiusolo, Myriam Labopin, Irma Khvedelidze, Frederic Baron, Eolia Brissot, Ali Bazarbachi, Gesine Bug, Jordi Esteve, Sebastian Giebel, Norbert Claude Gorin, Zina Peric, Francesco Lanza, Arnon Nagler, Simona Piemontese, Annalisa Ruggeri, Jaime Sanz, Bipin N. Savani, Christoph Schmidt, Roni Shouval, Alexandros Spyridonidis, Jurjen Versluis, Mohamad Mohty, Fabio Ciceri
Journal: Blood
Blood (2023) 142 (Supplement 1): 7049.
https://doi.org/10.1182/blood-2023-182831
Published: 2023
Journal Articles

Efficacy of Parallel and Crossover Analysis As Well As Pharmacokinetic Similarity Were Confirmed between ABP 959 and Eculizumab Reference Product in Patients with PNH

Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia MC Langemeijer, Satheesh Chonat, Jia Cao, Vincent Chow, Haby Henary
Journal: Blood
Blood (2023) 142 (Supplement 1): 4092.
https://doi.org/10.1182/blood-2023-186362
Published: 2023
Journal Articles

Applicability of SIE/Sies/GITMO Fitness Criteria to Therapy-Related and AML-MRC Receiving CPX-351: Results from a Large, Retrospective, Multicentric, Observational Study

Raffaele Palmieri, Fabio Guolo, Luana Fianchi, Felicetto Ferrara, Maria Paola Martelli, Michela Rondoni, Capria Saveria, Paola Minetto, Clara Minotti, Sofia Sciabolacci, Federica Pilo, Salvatore Perrone, Andrea Corbingi, Francesco Grimaldi, Giulia De Luca, Carla Fili, Caterina Alati, Francesco Mannelli, Federica Lessi, Francesco Marchesi, Lorenzo Brunetti, Debora Capelli, Anna Lina Piccioni, Calogero Vetro, Carla Mazzone, Alessandra Sperotto, Giovanni Luzi, Michelina Dargenio, Sabrina Mariani, Marco Cerrano, Antonino Mulè, Ambra Di Veroli, Cristina Papayannidis, Alessandro Isidori, Francesco Lanza, Michele Gottardi, Elisabetta Todisco, Livio Pagano, Roberto Massimo Lemoli, Francesco Buccisano, Adriano Venditti
Journal: Blood
Blood (2023) 142 (Supplement 1): 2891.
https://doi.org/10.1182/blood-2023-181142
Published: 2023
Journal Articles

Practice Patterns of Transplant Centers Regarding Maintenance Treatment Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: A Survey on Behalf of the EBMT Acute Leukemia Working Party

Iman Abou Dalle, Myriam Labopin, Irma Khvedelidze, Frederic Baron, Eolia Brissot, Gesine Bug, Jordi Esteve, Sebastian Giebel, Norbert Claude Gorin, Francesco Lanza, Arnon Nagler, Zina Peric, Simona Piemontese, Annalisa Ruggeri, Jaime Sanz, Bipin N. Savani, Christoph Schmid, Roni Shouval, Alexandros Spyridonidis, Jurjen Versluis, Fabio Ciceri, Ali Bazarbachi, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 7089.
https://doi.org/10.1182/blood-2023-187095
Published: 2023
Journal Articles

Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study

Clinical Trials & Observations
Guido Gini, Monica Tani, Alessandra Tucci, Luigi Marcheselli, Marina Cesaretti, Monica Bellei, Anna Pascarella, Filippo Ballerini, Mauro Petrini, Francesco Merli, Attilio Olivieri, Francesco Lanza, Ombretta Annibali, Vittorio Ruggero Zilioli, Anna Marina Liberati, Maria Chiara Tisi, Annalisa Arcari, Dario Marino, Gerardo Musuraca, Vincenzo Pavone, Alberto Fabbri, Samantha Pozzi, Donato Mannina, Caterina Plenteda, Melania Celli, Stefano Luminari
Journal: Blood
Blood (2023) 142 (17): 1438–1447.
https://doi.org/10.1182/blood.2022019173
Published: 2023
Includes: Supplemental data
Journal Articles

Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study

Marcos J.G. de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi, Michael T Hemmer, Mei-Jie Zhang, Fan Zhang, Richa Shah, Verna Welch, Saara Tikka, Erik Vandendries, Matthias Stelljes, David I. Marks, Wael Saber
Journal: Blood
Blood (2022) 140 (Supplement 1): 6023–6025.
https://doi.org/10.1182/blood-2022-160315
Published: 2022
Journal Articles

Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia

Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paoloni, Roberto Massimo Lemoli, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo G. Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Fabio Guolo, Edoardo La Sala, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Giovanni Martinelli
Journal: Blood
Blood (2022) 140 (Supplement 1): 1705–1707.
https://doi.org/10.1182/blood-2022-157393
Published: 2022
Journal Articles

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria

Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia M.C. Langemeijer, Satheesh Chonat, Vincent Chow, Jean Pan, Yaneth Saportas, Vladimir Hanes, Haby Henary
Journal: Blood
Blood (2022) 140 (Supplement 1): 8660–8662.
https://doi.org/10.1182/blood-2022-166722
Published: 2022
Journal Articles

INO-CD22: A Multi-Center, Real-Life Study on Inotuzumab-Ozogamicin Safety and Effectiveness in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Cristina Papayannidis, Patrizia Zappasodi, Nicola S Fracchiolla, Francesco Di Raimondo, Daniele Giovanni Mattei, Francesco Lanza, Endri Mauro, Maria Ilaria Del Principe, Erika Borlenghi, Monica Fumagalli, Elisabetta Todisco, Simona Sica, Nicola Di Renzo, Paolo De Fabritiis, Paolo Corradini, Daniele Vallisa, Fara Petruzziello, Mario Luppi, Fabrizio Pane, Felicetto Ferrara, Francesco Passamonti, Antonino Mulè, Chiara Zingaretti, Giovanni Marconi, Irene Valli, Elisabetta Petracci, Alberto Clemente, Giuseppe Nicola Saglio, Fabio Ciceri, Giovanni Martinelli
Journal: Blood
Blood (2021) 138 (Supplement 1): 4391.
https://doi.org/10.1182/blood-2021-149157
Published: 2021
Journal Articles

Olutasidenib (FT-2102) in Combination with Azacitidine Induces Durable Complete Remissions in Patients with mIDH1 Acute Myeloid Leukemia

Jorge E. Cortes, Jordi Esteve, Ashish Bajel, Karen Yee, Thorsten Braun, Stephane De Botton, Pierre Peterlin, Christian Recher, Xavier Thomas, Justin Watts, Montserrat Arnan Sangerman, Antonio Curti, Carolyn Grove, Brian A. Jonas, Francesco Lanza, Olivier Legrand, Pau Montesinos, Prapti Patel, Thomas Prebet, Eunice S. Wang, Olga Polyanskaya, Julie Brevard, Jennifer Sweeney, Pierre Fenaux, Andrew H. Wei
Journal: Blood
Blood (2021) 138 (Supplement 1): 698.
https://doi.org/10.1182/blood-2021-144905
Published: 2021
Journal Articles

Results of the 6-Year Follow-up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia

Adriano Venditti, Alfonso Piciocchi, Raffaele Palmieri, Valentina Arena, Anna Candoni, Valeria Calafiore, Lorella MA Melillo, Roberto Cairoli, Paolo De Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Mario Luppi, Saveria Capria, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Elisa Buzzatti, Maria Teresa Voso, Tiziana Ottone, Maria irno Consalvo, Paola Fazi, Marco Vignetti, William Arcese, Sergio Amadori, Francesco Buccisano
Journal: Blood
Blood (2021) 138 (Supplement 1): 2359.
https://doi.org/10.1182/blood-2021-147200
Published: 2021
Journal Articles

Long-Term Outcome of Peripheral Blood Autologous Stem Cell Transplantation (AutoSCT) for De Novo Acute Myeloid Leukemia in Patients Achieving First Complete Remission after One Vs Two Induction Courses: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Arnon Nagler, Jacques-Emmanuel Galimard, Myriam Labopin, Didier Blaise, William Arcese, Depei Wu, Gwendolyn Van Gorkom, Marie Thérèse Rubio, Tobias Gedde-Dahl, Anne Huynh, Francesco Lanza, Norbert Claude Gorin, Sr., Mohamad Mohty, Silvia Maria Trisolini, Arnaud Pigneux
Journal: Blood
Blood (2021) 138 (Supplement 1): 1840.
https://doi.org/10.1182/blood-2021-145031
Published: 2021
Journal Articles

Validation of ELN2017 Risk Stratification in a Post-Hoc Analysis of the Prospective Biomarker-Based Gimema AML1310 Protocol

Raffaele Palmieri, MD, Francesco Buccisano, MD, Alfonso Piciocchi, MS, Valentina Arena, MS, Anna Candoni, Lorella MA Melillo, MD, Valeria Calafiore, Roberto Cairoli, MD, Paolo De Fabritiis, MD, Gabriella Storti, Prassede Salutari, MD, Francesco Lanza, MD, Giovanni Martinelli, MD, Mario Luppi, Saveria Capria, MD, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Maria Teresa Voso, MD, Tiziana Ottone, Serena Lavorgna, Paola Fazi, MD, Marco Vignetti, MD, William Arcese, MD PhD, Adriano Venditti, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-139773
Published: 2020
Journal Articles

Preliminary Results from CPX-351 Italian Compassionate Use Program Show High Response Rate and Good Tolerability in Poor Prognosis AML Patients

Fabio Guolo, MD, Paola Minetto, MD, Luana Fianchi, MD, Michela Rondoni, MD, Giulia Daghia, MD, Stefano D'Ardia, MD, Monica Morselli, MD, Crescenza Pasciolla, MD, Francesca Pavesi, MD, Barbara MD Scappini, Francesco Lanza, MD, Marco Gobbi, MD, Livio Pagano, MD, Felicetto Ferrara, MD, Roberto Massimo Lemoli, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1363.
https://doi.org/10.1182/blood-2019-131329
Published: 2019
Journal Articles

CD34+ Cell Dose Effects on Clinical Outcomes of Patients with Acute Myeloid Leukemia after T-Replete Haploidentical Allogeneic Hematopoietic Stemcell Transplantation Using Peripheral Blood Stem Cells. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Enrico Maffini, MD, Myriam Labopin, MD, Didier Blaise, MD PhD, Fabio Ciceri, MD, Zafer Gulbas, MD, Etienne Daguindau, Stephanie Nguyen-Quoc, MD, Patrice Chevallier, MD, Gerard Socie, MD PhD, Mercedes Colorado, MD, Yener Koc, MD, Francesco Lanza, MD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4586.
https://doi.org/10.1182/blood-2019-123987
Published: 2019